CN114875104B - 一种桑叶酵素原液及其制备方法和应用 - Google Patents
一种桑叶酵素原液及其制备方法和应用 Download PDFInfo
- Publication number
- CN114875104B CN114875104B CN202210198402.1A CN202210198402A CN114875104B CN 114875104 B CN114875104 B CN 114875104B CN 202210198402 A CN202210198402 A CN 202210198402A CN 114875104 B CN114875104 B CN 114875104B
- Authority
- CN
- China
- Prior art keywords
- mulberry leaf
- stock solution
- culture medium
- clostridium butyricum
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000008708 Morus alba Nutrition 0.000 title claims abstract description 102
- 240000000249 Morus alba Species 0.000 title claims abstract description 101
- 239000011550 stock solution Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 238000000855 fermentation Methods 0.000 claims abstract description 67
- 230000004151 fermentation Effects 0.000 claims abstract description 63
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 56
- 241000193171 Clostridium butyricum Species 0.000 claims abstract description 51
- 239000001963 growth medium Substances 0.000 claims abstract description 48
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 30
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 28
- 229960003495 thiamine Drugs 0.000 claims abstract description 28
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 28
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 28
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 28
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 26
- 241000001727 Tropicoporus linteus Species 0.000 claims abstract description 26
- 241000186660 Lactobacillus Species 0.000 claims abstract description 22
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 235000012907 honey Nutrition 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 238000009630 liquid culture Methods 0.000 claims abstract description 7
- 238000005520 cutting process Methods 0.000 claims abstract description 4
- 230000003716 rejuvenation Effects 0.000 claims description 25
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 24
- 239000002609 medium Substances 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000008223 sterile water Substances 0.000 claims description 13
- 108010024636 Glutathione Proteins 0.000 claims description 12
- 229960003180 glutathione Drugs 0.000 claims description 12
- 150000004676 glycans Chemical class 0.000 claims description 11
- 229920001282 polysaccharide Polymers 0.000 claims description 11
- 239000005017 polysaccharide Substances 0.000 claims description 11
- 241000223651 Aureobasidium Species 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 239000001888 Peptone Substances 0.000 claims description 9
- 108010080698 Peptones Proteins 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 235000019319 peptone Nutrition 0.000 claims description 9
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 8
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 claims description 7
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 claims description 7
- 229940099596 manganese sulfate Drugs 0.000 claims description 7
- 239000011702 manganese sulphate Substances 0.000 claims description 7
- 235000007079 manganese sulphate Nutrition 0.000 claims description 7
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 6
- -1 tocopheryl palmitate Chemical compound 0.000 claims description 6
- 238000009629 microbiological culture Methods 0.000 claims description 4
- 230000001502 supplementing effect Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 31
- 230000000694 effects Effects 0.000 description 11
- 108010054320 Lignin peroxidase Proteins 0.000 description 9
- 210000002421 cell wall Anatomy 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 7
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 7
- 229960001295 tocopherol Drugs 0.000 description 7
- 229930003799 tocopherol Natural products 0.000 description 7
- 235000010384 tocopherol Nutrition 0.000 description 7
- 239000011732 tocopherol Substances 0.000 description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 7
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000123107 Phellinus Species 0.000 description 5
- 235000010633 broth Nutrition 0.000 description 5
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 229960000907 methylthioninium chloride Drugs 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 241000223678 Aureobasidium pullulans Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 238000012262 fermentative production Methods 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 241000186684 Lactobacillus pentosus Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000218213 Morus <angiosperm> Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/005—Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/167—Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
组别 | 维生素B1的含量(mg/100g) |
实施例5 | 1.63 |
实施例6 | 2.06 |
实施例7 | 2.18 |
对比例4 | 0.87 |
对比例5 | 0.90 |
对比例6 | 0.84 |
组别 | γ-氨基丁酸的含量(g/L) |
实施例5 | 0.029 |
实施例6 | 0.031 |
实施例7 | 0.035 |
对比例3 | 0.025 |
对比例4 | 0.020 |
对比例5 | 0.019 |
对比例6 | 0.021 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210198402.1A CN114875104B (zh) | 2022-03-02 | 2022-03-02 | 一种桑叶酵素原液及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210198402.1A CN114875104B (zh) | 2022-03-02 | 2022-03-02 | 一种桑叶酵素原液及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114875104A CN114875104A (zh) | 2022-08-09 |
CN114875104B true CN114875104B (zh) | 2023-08-29 |
Family
ID=82668299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210198402.1A Active CN114875104B (zh) | 2022-03-02 | 2022-03-02 | 一种桑叶酵素原液及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114875104B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010004103A (ko) * | 1999-06-28 | 2001-01-15 | 류인덕 | 미생물 발효를 이용한 뽕잎 건강식품의 제조방법 |
CN104975051A (zh) * | 2015-06-25 | 2015-10-14 | 江苏科技大学 | 一种富集桑叶中gaba的方法 |
CN105285625A (zh) * | 2015-10-12 | 2016-02-03 | 江苏科技大学 | 一种富含gaba的桑叶酵素饮料原液及其制备方法和应用 |
KR20170134921A (ko) * | 2016-05-27 | 2017-12-07 | 다인바이오 주식회사 | 발효 뽕잎, 발효 뽕잎 추출물 및 이의 용도 |
JP2020115761A (ja) * | 2019-01-21 | 2020-08-06 | 台灣中油股▲ふん▼有限公司 | γーアミノ酪酸高産出の調理方法 |
CN112501077A (zh) * | 2020-12-17 | 2021-03-16 | 清远希普生物科技有限公司 | 一种丁酸梭菌的培养方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200811288A (en) * | 2006-02-21 | 2008-03-01 | Kikkoman Corp | Lactic acid bacterium capable of producing gamma-aminobutyric acid |
-
2022
- 2022-03-02 CN CN202210198402.1A patent/CN114875104B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010004103A (ko) * | 1999-06-28 | 2001-01-15 | 류인덕 | 미생물 발효를 이용한 뽕잎 건강식품의 제조방법 |
CN104975051A (zh) * | 2015-06-25 | 2015-10-14 | 江苏科技大学 | 一种富集桑叶中gaba的方法 |
CN105285625A (zh) * | 2015-10-12 | 2016-02-03 | 江苏科技大学 | 一种富含gaba的桑叶酵素饮料原液及其制备方法和应用 |
KR20170134921A (ko) * | 2016-05-27 | 2017-12-07 | 다인바이오 주식회사 | 발효 뽕잎, 발효 뽕잎 추출물 및 이의 용도 |
JP2020115761A (ja) * | 2019-01-21 | 2020-08-06 | 台灣中油股▲ふん▼有限公司 | γーアミノ酪酸高産出の調理方法 |
CN112501077A (zh) * | 2020-12-17 | 2021-03-16 | 清远希普生物科技有限公司 | 一种丁酸梭菌的培养方法 |
Non-Patent Citations (1)
Title |
---|
龚福明 ; 柳陈坚 ; 李晓然 ; .植物乳杆菌YM-4-3发酵合成γ-氨基丁酸的条件优化.昆明理工大学学报(自然科学版).2017,(第04期), * |
Also Published As
Publication number | Publication date |
---|---|
CN114875104A (zh) | 2022-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111317694B (zh) | 一种杜仲发酵提取液及其制备方法和其在化妆品中的应用 | |
US11279961B2 (en) | Aspergillus oryzae BLCY-006 strain and application thereof in preparation of galactooligosaccharide | |
CN112553284B (zh) | 一种自然共生的混合培养物降解粗饲料生产柠檬酸的方法 | |
JP2019193634A (ja) | 低糖な野菜および/または果物の酵素液の製造方法 | |
CN116019185B (zh) | 一种副干酪乳杆菌在制备发酵枸杞中的应用 | |
CN114107403B (zh) | 一种微生物群落发酵石榴皮联产鞣花酸和生物饲料的方法 | |
CN114052153B (zh) | 一种多功能发酵饮料及其制备方法 | |
CN113801806B (zh) | 索诺拉沙漠芽孢杆菌及其在降解黄曲霉毒素中的应用 | |
CN101358173A (zh) | 黑曲霉zjut712及其在固态发酵炮制牛蒡子中的应用 | |
CN102796670B (zh) | 一种黑曲霉菌株及其应用 | |
CN110904156B (zh) | 一种提高桑黄液态发酵三萜产量的方法 | |
CN112586596A (zh) | 一种提高茶渣营养价值的固态发酵方法 | |
CN110551636B (zh) | 一种紫红曲霉my-21菌株及其应用 | |
CN112746022A (zh) | 一种预防蝙蝠蛾拟青霉发酵菌丝体中腺苷流失的方法 | |
CN114875104B (zh) | 一种桑叶酵素原液及其制备方法和应用 | |
CN111388515A (zh) | 红曲霉液态发酵人参的方法及人参发酵产物和用途 | |
CN114181842B (zh) | 一株转化花青素产原儿茶酸的扣囊复膜酵母cx-3菌株及其应用 | |
CN116103161A (zh) | 一种产泽兰素的植物内生真菌及其应用 | |
CN109456898A (zh) | 一种球毛壳菌右旋糖酐酶的发酵制备及其应用 | |
CN110607332B (zh) | 一种提高功能性红曲Monacolin K含量的培养基及发酵方法 | |
CN114369558B (zh) | 一株粘质沙雷氏菌及其在生产柚苷酶中的应用 | |
CN111500657B (zh) | 一种联产竹红菌甲素和竹黄胞外多糖的方法 | |
CN115627280A (zh) | 一种高产γ-氨基丁酸和红曲色素的发酵液的制备方法 | |
CN117547572B (zh) | 一种组合物的复合乳酸菌发酵品的制备方法、产品及应用 | |
CN115251203B (zh) | 谢瓦氏曲霉在发酵制备牡丹花瓣茶中的应用及方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Room 409, 4th Floor, No. 3, Yiheng Road, Datian, Hebian, Hebian, Helong Street, Baiyun District, Guangzhou City, Guangdong Province, 510000 Applicant after: Guangzhou Bafeiba Health Industry Co.,Ltd. Address before: 510440 room 913, floor 9, No. 629, Helong 1st Road, Helong street, Baiyun District, Guangzhou, Guangdong Applicant before: Guangzhou Mujia Health Industry Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240311 Address after: 236000, Room 315, 2.5 Industrial Park, Bowu Modern Industrial Park, Hehuan Road, High tech Zone, Bozhou City, Anhui Province Patentee after: Bafeiba Food Technology Co.,Ltd. Country or region after: China Address before: Room 409, 4th Floor, No. 3, Yiheng Road, Datian, Hebian, Hebian, Helong Street, Baiyun District, Guangzhou City, Guangdong Province, 510000 Patentee before: Guangzhou Bafeiba Health Industry Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |